Navidea Biopharmaceuticals Inc (NAVB)
0.0382
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Navidea Biopharmaceuticals Max Drawdown (5Y): 99.36% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.36% |
| March 31, 2024 | 99.36% |
| February 29, 2024 | 99.36% |
| January 31, 2024 | 99.36% |
| December 31, 2023 | 99.36% |
| November 30, 2023 | 99.36% |
| October 31, 2023 | 99.36% |
| September 30, 2023 | 99.03% |
| August 31, 2023 | 99.03% |
| July 31, 2023 | 98.96% |
| June 30, 2023 | 98.96% |
| May 31, 2023 | 98.96% |
| April 30, 2023 | 98.96% |
| March 31, 2023 | 98.96% |
| February 28, 2023 | 98.96% |
| January 31, 2023 | 98.96% |
| December 31, 2022 | 98.96% |
| November 30, 2022 | 98.96% |
| October 31, 2022 | 98.96% |
| September 30, 2022 | 98.96% |
| August 31, 2022 | 98.96% |
| July 31, 2022 | 98.96% |
| June 30, 2022 | 98.96% |
| May 31, 2022 | 98.96% |
| April 30, 2022 | 98.96% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.96% |
| February 28, 2022 | 98.96% |
| January 31, 2022 | 98.96% |
| December 31, 2021 | 98.96% |
| November 30, 2021 | 98.96% |
| October 31, 2021 | 98.96% |
| September 30, 2021 | 98.96% |
| August 31, 2021 | 98.96% |
| July 31, 2021 | 98.96% |
| June 30, 2021 | 98.96% |
| May 31, 2021 | 98.96% |
| April 30, 2021 | 98.96% |
| March 31, 2021 | 98.96% |
| February 28, 2021 | 98.96% |
| January 31, 2021 | 98.96% |
| December 31, 2020 | 98.96% |
| November 30, 2020 | 98.96% |
| October 31, 2020 | 98.96% |
| September 30, 2020 | 98.96% |
| August 31, 2020 | 98.96% |
| July 31, 2020 | 98.96% |
| June 30, 2020 | 98.96% |
| May 31, 2020 | 98.96% |
| April 30, 2020 | 98.96% |
| March 31, 2020 | 98.96% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
97.41%
Minimum
May 2019
99.36%
Maximum
Oct 2023
98.98%
Average
98.96%
Median
Aug 2019
Max Drawdown (5Y) Benchmarks
| Perspective Therapeutics Inc | 91.70% |
| Electromed Inc | 55.84% |
| Xtant Medical Holdings Inc | 98.66% |
| Asensus Surgical Inc | 99.68% |
| Senseonics Holdings Inc | 92.82% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -71.15 |
| Beta (5Y) | 1.135 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 132.0% |
| Historical Sharpe Ratio (5Y) | -0.4432 |
| Historical Sortino (5Y) | -1.209 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.95% |